BenevolentAI has moved its AI-discovered drug for Batten disease, a neurodegenerative disorder affecting children, into Phase 2 trials, showing promise in early studies. (August 25, 2024)
September 4, 2024
BenevolentAI has moved its AI-discovered drug for Batten disease, a neurodegenerative disorder affecting children, into Phase 2 trials, showing promise in early studies. (August 25, 2024)
Medico is a pharmaceutical and healthcare
products distribution company based in UAE
Quick Links
Special
© 2024 by NaqsTech Digital | All Rights Reserved | Powered by Medico.